Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Locally Recurrent or Metastatic Breast Cancer
Interventions: DRUG: Imetelstat sodium|DRUG: Bevacizumab|DRUG: Paclitaxel
Sponsor: Geron Corporation